Literature DB >> 17805280

HIV/AIDS: allied responses.

John R Mascola.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17805280     DOI： 10.1038/449029a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

1.  Enhanced HIV-1 neutralization by antibody heteroligation.

Authors:  Hugo Mouquet; Malte Warncke; Johannes F Scheid; Michael S Seaman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-04       Impact factor: 11.205

2.  Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.

Authors:  Sandra D Taylor; Steven R Leib; Susan Carpenter; Robert H Mealey
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

Review 3.  Role of humoral immunity in host defense against HIV.

Authors:  Linda L Baum
Journal:  Curr HIV/AIDS Rep       Date:  2010-02       Impact factor: 5.071

Review 4.  Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines.

Authors:  Jean-Louis Excler; Julie Ake; Merlin L Robb; Jerome H Kim; Stanley A Plotkin
Journal:  Clin Vaccine Immunol       Date:  2014-06-11

5.  Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation.

Authors:  Hugo Mouquet; Johannes F Scheid; Markus J Zoller; Michelle Krogsgaard; Rene G Ott; Shetha Shukair; Maxim N Artyomov; John Pietzsch; Mark Connors; Florencia Pereyra; Bruce D Walker; David D Ho; Patrick C Wilson; Michael S Seaman; Herman N Eisen; Arup K Chakraborty; Thomas J Hope; Jeffrey V Ravetch; Hedda Wardemann; Michel C Nussenzweig
Journal:  Nature       Date:  2010-09-30       Impact factor: 49.962

6.  Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.

Authors:  Johannes F Scheid; Hugo Mouquet; Niklas Feldhahn; Michael S Seaman; Klara Velinzon; John Pietzsch; Rene G Ott; Robert M Anthony; Henry Zebroski; Arlene Hurley; Adhuna Phogat; Bimal Chakrabarti; Yuxing Li; Mark Connors; Florencia Pereyra; Bruce D Walker; Hedda Wardemann; David Ho; Richard T Wyatt; John R Mascola; Jeffrey V Ravetch; Michel C Nussenzweig
Journal:  Nature       Date:  2009-03-15       Impact factor: 49.962

7.  Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.

Authors:  Hugo Mouquet; Louise Scharf; Zelda Euler; Yan Liu; Caroline Eden; Johannes F Scheid; Ariel Halper-Stromberg; Priyanthi N P Gnanapragasam; Daniel I R Spencer; Michael S Seaman; Hanneke Schuitemaker; Ten Feizi; Michel C Nussenzweig; Pamela J Bjorkman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-30       Impact factor: 11.205

8.  Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses.

Authors:  Hugo Mouquet; Florian Klein; Johannes F Scheid; Malte Warncke; John Pietzsch; Thiago Y K Oliveira; Klara Velinzon; Michael S Seaman; Michel C Nussenzweig
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

Review 9.  An Outdated Notion of Antibody Specificity is One of the Major Detrimental Assumptions of the Structure-Based Reverse Vaccinology Paradigm, Which Prevented It from Helping to Develop an Effective HIV-1 Vaccine.

Authors:  Marc H V Van Regenmortel
Journal:  Front Immunol       Date:  2014-11-18       Impact factor: 7.561

10.  Improving defences at the portal of HIV entry: mucosal and innate immunity.

Authors:  Robin J Shattock; Barton F Haynes; Bali Pulendran; Jorge Flores; José Esparza
Journal:  PLoS Med       Date:  2008-04-01       Impact factor: 11.069
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.